Lv11
10 积分 2023-05-30 加入
Cancer cell plasticity during tumor progression, metastasis and response to therapy
12分钟前
待确认
Targeting monocyte-intrinsic enhancer reprogramming improves immunotherapy efficacy in hepatocellular carcinoma
3个月前
已完结
The peritumor microenvironment: physics and immunity
8个月前
已完结
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study
8个月前
已完结
Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2–3 study
8个月前
已完结
Metabolic barriers to cancer immunotherapy
8个月前
已完结
Immunotherapy for hepatocellular carcinoma
8个月前
已完结
The Relationship between Angiotensin–Neprilysin Treatment, Echocardiographic Parameters, and NT-proBNP Levels in HFpEF Patients with Acute Decompensated Heart Failure
1年前
已完结
A subset of neutrophils activates anti-tumor immunity and inhibits non-small-cell lung cancer progression
1年前
已完结